Filters

See more specimen types...

Other countries

Results: 1 to 20 of 40

Tests names and labsConditionsGenes and analytesMethods

Ventricular tachycardia, catecholaminergic polymorphic type 2

Centogene AG - the Rare Disease Company
Germany
11
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Pan Cardiomyopathy Panel (62 Genes)

Laboratory for Molecular Medicine Partners HealthCare Personalized Medicine
United States
10362
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

DCM/Arrhythmogenic Cardiomyopathy Panel (53 Genes)

Laboratory for Molecular Medicine Partners HealthCare Personalized Medicine
United States
9753
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Comprehensive Cardiac Arrhythmia NextGen Sequencing (NGS) Panel

PreventionGenetics
United States
5246
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

Arrythmogenic Cardiomyopathy Panel

Health in Code S.L.
Spain
5517
  • C Sequence analysis of the entire coding region

RYR2. Complete sequencing

Instituto de Medicina Genomica
Spain
21
  • C Sequence analysis of the entire coding region

RYR2. Sequencing of the 30 \\\\

Instituto de Medicina Genomica
Spain
21
  • E Sequence analysis of select exons

CASQ2. Complete sequencing

Instituto de Medicina Genomica
Spain
21
  • C Sequence analysis of the entire coding region

Catecholaminergic Polymorphic Ventricular Tachycardia Sequencing Panel

PreventionGenetics
United States
58
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

Catecholaminergic Polymorphic Ventricular Tachycardia via the CASQ2 gene

PreventionGenetics
United States
11
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

Catecholaminergic Polymorphic Ventricular Tachycardia

GENETAQ Molecular Genetics Centre and Diagnosis of Rare Diseases
Spain
77
  • C Sequence analysis of the entire coding region

Catecholaminergic polymorphic ventricular tachycardia

GENETAQ Molecular Genetics Centre and Diagnosis of Rare Diseases
Spain
85
  • C Sequence analysis of the entire coding region

Invitae Arrhythmia and Cardiomyopathy Comprehensive Panel

Invitae
United States
116119
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

CASQ2

MVZ Dortmund Dr. Eberhard and Partner
Germany
11
  • C Sequence analysis of the entire coding region

CASQ2 Gene Sequencing

DDC Molecular Diagnostics Laboratory DDC Clinic, Center for Special Needs Children
United States
11
  • C Sequence analysis of the entire coding region

Catecholaminergic polymorphic ventricular tachycardia type 2

Bioarray
Spain
11
  • C Sequence analysis of the entire coding region

Cardiac conduction changes (NGS panel for 27 genes)

CGC Genetics
Portugal
2627
  • C Sequence analysis of the entire coding region

Catecholaminergic Polymorphic Ventricular Tachycardia NGS Panel

DDC Molecular Diagnostics Laboratory DDC Clinic, Center for Special Needs Children
United States
96
  • C Sequence analysis of the entire coding region

Comprehensive Cardiovascular: Sequencing Panel

Emory Genetics Laboratory Emory University
United States
42106
  • C Sequence analysis of the entire coding region

Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT), Paroxysmal/ Idiopathic Ventricular Fibrillation / Tachycardia Panel

CeGaT GmbH
Germany
510
  • C Sequence analysis of the entire coding region

Results: 1 to 20 of 40

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.